Targeting glioblastoma stem-cells: a recurrent challenge in neurooncology
Sign Up to like & getrecommendations! Published in 2017 at "Translational cancer research"
DOI: 10.21037/16225
Abstract: Glioblastoma (GBM) is the most common and most aggressive primary brain tumor in adults. To date, this tumor remains rapidly fatal despite treatment, median overall survival not exceeding 15 months from diagnosis (1). read more here.
Keywords: recurrent challenge; targeting glioblastoma; cells recurrent; challenge neurooncology ... See more keywords